simvastatin has been researched along with Bone Diseases, Metabolic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, BL; Cui, W; Huang, ZL; Li, H; Lv, YX; Sun, T; Tao, ZS; Tu, KK; Yang, L; Yu, XB; Zhou, Q; Zhou, WS | 1 |
Chuengsamarn, S; Kaufman, L; Rattanamongkoulgul, S; Suwanwalaikorn, S; Wattanasirichaigoon, S | 1 |
Kiriliuk, IN; Kochetkova, EA; Semisotova, EF | 1 |
1 trial(s) available for simvastatin and Bone Diseases, Metabolic
Article | Year |
---|---|
Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
Topics: Aged; Bone Density; Bone Diseases, Metabolic; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Osteogenesis; Patient Selection; Prospective Studies; Simvastatin; Treatment Outcome | 2010 |
2 other study(ies) available for simvastatin and Bone Diseases, Metabolic
Article | Year |
---|---|
The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs.
Topics: Animals; Arthroplasty, Replacement, Hip; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Regeneration; Coated Materials, Biocompatible; Dietary Proteins; Female; Femur; Hip Prosthesis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Implants, Experimental; Osseointegration; Parathyroid Hormone; Random Allocation; Rats; Rats, Sprague-Dawley; Simvastatin; Titanium | 2016 |
[Experience with simvastatin therapy for the achievement of osteoprotective effects in women with hyperlipidemia].
Topics: Absorptiometry, Photon; Biological Availability; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Collagen; Diet, Fat-Restricted; Drug Monitoring; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Middle Aged; Osteocalcin; Peptide Fragments; Protective Agents; Simvastatin; Treatment Outcome | 2012 |